$0.8310
-0.06-6.36%
At close: -
$0.8297
-0.00130-0.16%
After Hours: Dec 20, 6:56 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Oncolytics Biotech in recent months.
Browse guidance and forecast on all stocks.